Chotosan, a Kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition behaviors and central cholinergic systems in mice

Journal of Pharmacological Sciences

Volumn 103, Issue 4, 2007, Pages 360-373

  Zhao, Qi ^a   Murakami, Yukihisa ^a   Tohda, Michihisa ^a   Obi, Ryosuke ^a   Shimada, Yutaka ^a   Matsumoto, Kinzo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cholinergic system; Chotosan; Chronic cerebral hypoperfusion; Mouse model; Object recognition memory deficit

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CHOTOSAN; KAMPO; MUSCARINIC RECEPTOR; SAIKOKEISHITO; TACRINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN PERFUSION; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG FORMULARY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RECOGNITION;

EID: 34247376578     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0061457     Document Type: Article

References (43)

1. Meguro K, Ishii H, Yamaguchi S, Ishizaki J, Shimada M, Sato M, et al. Prevalence of dementia and dementing diseases in Japan: the Tajiri project. Arch Neurol. 2002;59:1109-1114.
2. Terasawa K, Shimada Y, Kita T, Yamamoto T, Tosa H, Tanaka N, et al. Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study. Phytomedicine. 1997;4:15-22.
3. Shimada Y, Terasawa K, Yamamoto T, Maruyama I, Saitoh Y, Kanaki E, et al. A well-controlled study of Cho-to-san and placebo in the treatment of vascular dementia. J Trad Med. 1994;11:246-255.
4. Shimada Y, Yang Q, Yokoyama K, Goto H, Kasahara Y, Sekiya N, et al. Choto-san prevents occurrence of stroke and prolongs life span in stroke-prone spontaneously hypertensive rats. Am J Chin Med. 2003;31:79-85.
5. Watanabe H, Zhao Q, Matsumoto K, Tohda M, Murakami Y, Zhang SH, et al. Pharmacological evidence for antidementia effect of Choto-san (Gouteng-san), a traditional Kampo medicine. Pharmacol Biochem Behav. 2003;75:635-643.
6. Mahakunakorn P, Tohda M, Murakami Y, Matsumoto K, Watanabe H. Antioxidant and free radical-scavenging activity of Choto-san and its related constituents. Biol Pharm Bull. 2004;27:38-46.
7. Kang TH, Murakami Y, Matsumoto K, Takayama H, Kitajima M, Aimi N, et al. Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytes. Eur J Pharmacol. 2002;455:27-34.
8. Kang TH, Murakami Y, Takayama H, Kitajima M, Aimi N, Watanabe H, et al. Protective effect of rhynchophylline and isorhynchophylline on in vitro ischemia-induced neuronal damage in the hippocampus: putative neurotransmitter receptors involved in their action. Life Sci. 2004;76:331-343.
9. Ni JW, Ohta H, Matsumoto K, Watanabe H. Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral common carotid arteries in rats. Brain Res. 1994;653:231-236.
10. Ni JW, Matsumoto K, Li HB, Murakami Y, Watanabe H. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res. 1995;673:290-296.
11. Pappas BA, de la Torre JC, Davidson CM, Keyes MT, Fortin T. Chronic reduction of cerebral blood flow in the adult rat: late-emerging CA1 cell loss and memory dysfunction. Brain Res. 1996;708:50-58.
12. Sarti C, Pantoni L, Bartolini L, Inzitari D. Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat. Behav Brain Res. 2002;136:13-20.
13. Ni JW, Matsumoto K, Watanabe H. Tetramethylpyrazine improves spatial cognitive impairment induced by permanent occlusion of bilateral common carotid arteries or scopolamine in rats. Jpn J Pharmacol. 1995;67:137-141.
14. Nanri M, Miyake H, Murakami Y, Matsumoto K, Watanabe H. GTS-21, a nicotinic agonist, attenuates multiple infarctions and cognitive deficit caused by permanent occlusion of bilateral common carotid arteries in rats. Jpn J Pharmacol. 1998;78:463-469.
15. Murakami Y, Ikenoya M, Matsumoto K, Li HB, Watanabe H. Ameliorative effect of tacrine on spatial memory deficit in chronic two-vessel occluded rats is reversible and mediated by muscarinic M1 receptor stimulation. Behav Brain Res. 2000;109:83-90.
16. Murakami Y, Zhao Q, Harada K, Tohda M, Watanabe H, Matsumoto K. Choto-san, a Kamp formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor. Pharmacol Biochem Behav. 2005;81:616-625.
17. Murakami Y, Tanaka E, Sakai Y, Matsumoto K, Li HB, Watanabe H. Tacrine improves working memory deficit caused by permanent occlusion of bilateral common carotid arteries in rats. Jpn J Pharmacol. 1997;75:443-446.
18. Ohta Y, Kobayashi T, Hayashi T, Inui K, Yoshino J. Saikokeishito extract prevents progression of acute gastric mucosal lesion induced by compound48/80, a mast cell degranulator, in rats. J Trad Med. 2006;23:101-111.
19. Zhao Q, Murakami Y, Tohda M, Watanabe H, Matsumoto K. Preventive effect of chotosan, a Kampo medicine, on transient ischemia-induced learning deficit is mediated by stimulation of muscarinic M1 but not nicotinic receptor. Biol Pharm Bull. 2005;28:1873-1878.
20. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, et al. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci U S A. 2005;102:3811-3816.
21. Ellman GL, Courtney KD, Andres JJ, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95.
22. Uz T, Ahmed R, Akhisaroglu M, Kurtuncu M, Imbesi M, Dirim Arslan A, et al. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience. 2005;134:1309-1316.
23. Lee I, Hunsaker MR, Kesner RP. The role of hippocampal subregions in detecting spatial novelty. Behav Neurosci. 2005;119:145-153.
24. Murai T, Okuda S, Tanaka T, Ohta H. Characteristics of object location memory in mice: behavioral and pharmacological studies. Physiol Behav. 2007;90:116-124.
25. Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H. Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn Mem. 2002;9:49-57.
26. Bartolini L, Casamenti F, Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav. 1996;53:277-283.
27. Whinters BD, Bussey TJ. Removal of cholinergic input to perirhinal cortex disrupts object recognition but not spatial working memory in the rat. Eur J Neurosci. 2005;21:2263-2270.
28. Murray EA, Richmond BJ. Role of perirhinal cortex in object perception, memory, and associations. Curr Opin Neurobiol. 2001;11:188-193.
29. Scali C, Casamenti F, Pazzagli M, Bartolini L, Pepeu G. Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. Neurosci Lett. 1994;170:117-120.
30. Scali C, Giovannii MG, Bartolini L, Prosperi C, Hinz V, Schmidt B, et al. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. Eur J Pharmacol. 1997;325:173-180.
31. Horie Y, Kajihara M, Yamagishi Y, Kimura H, Tamai H, Kata S, et al. Japanese herbal medicine, Saiko-keishi-to, prevents gut ischemia/reperfusion- induced liver injury in rats via nitric oxide. World J. Gastroenterol. 2004;10:2241-2244.
32. Niewiadomska G, Baksalerska-Pazera M, Gasiorowska A, Mietelska A. Nerve growth factor differentially affects spatial and recognition memory in aged rats. Neurochem Res. 2006;31:1481-1490.
33. Pongrac JL, Rylett RJ. Differential effects of nerve growth factor on expression of choline acetyltransferase and sodium-coupled choline transport in basal forebrain cholinergic neurones in culture. J Neurochem. 1996;66:804-810.
34. Pongrac JL, Rylett RJ. Molecular mechanisms regulating NGF-mediated enhancement of cholinergic neuronal phenotype: c-fos trans-activation of the choline acetyltransferase gene. J Mol Neurosci. 1998;11:79-93.
35. Kato K, Hayako H, Ishihara Y, Marui S, Iwane M, Miyamoto M. TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons. Neurosci Lett. 1999;260:5-8.
36. Zhang G, Zhang L, Logan R, Jung BP, Yuen D, Ching Hsu J, et al. Decreased expression and impaired function of muscarinic acetylcholine receptors in the rat hippocampus following transient forebrain ischemia. Neurobiol Dis. 2005;20:805-813.
37. Tanaka K, Mizukawa K, Ogawa N, Mori A. Post-ischemic administration of the acetylcholinesterase inhibitor ENA-713 prevents delayed neuronal death in the gerbil hippocampus. Neurochem Res. 1995;20:663-667.
38. Tanaka K, Ogawa N, Mizukawa K, Asanuma M, Kondo Y, Nishibayashi S, et al. Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and post-synaptic cholinergic indices in the gerbil brain following transient ischemia. Neurochem Res. 1994;19:117-122.
39. 3 muscarinic acetylcholine receptors in mammalian hearts. Br J Pharmacol. 2004;142:395-408.
40. Yan G-M, Lin S-Z, Irwin RP, Paul SM. Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons. Mol Pharmacol. 1995;47:248-257.
41. 3 subtype muscarinic acetylcholine receptors. Cell Physiol Biochem. 2005;16:163-174.
42. Phillips JK, Vidovic M, Hill CE. Variation in mRNA expression of alpha-adrenergic, neurokinin and muscarinic receptors amongst four arteries of the rat. J Auton Nerv Syst. 1997;62:85-93.
43. Wess J. Muscrinic acetylcholine receptor knockout mice: novel phenotype and clinical implications. Annu Rev Pharmacol Toxicol. 2004;44:423-450.